Medtronic plc (BVMF:MDTC34)

Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of BRL 693.27 billion. The enterprise value is 804.30 billion.

Market Cap	693.27B
Enterprise Value	804.30B

Important Dates

The last earnings date was Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	Sep 25, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.73%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	86.98%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 27.02 and the forward PE ratio is 17.37.

PE Ratio	27.02
Forward PE	17.37
PS Ratio	3.70
PB Ratio	2.63
P/TBV Ratio	n/a
P/FCF Ratio	24.72
P/OCF Ratio	18.09
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.36, with an EV/FCF ratio of 28.68.

EV / Earnings	31.34
EV / Sales	4.36
EV / EBITDA	15.36
EV / EBIT	22.31
EV / FCF	28.68

Financial Position

The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.60.

Current Ratio	2.42
Quick Ratio	1.48
Debt / Equity	0.60
Debt / EBITDA	2.95
Debt / FCF	5.59
Interest Coverage	9.57

Financial Efficiency

Return on equity (ROE) is 9.82% and return on invested capital (ROIC) is 5.48%.

Return on Equity (ROE)	9.82%
Return on Assets (ROA)	4.68%
Return on Invested Capital (ROIC)	5.48%
Return on Capital Employed (ROCE)	8.35%
Revenue Per Employee	1.97M
Profits Per Employee	270,119
Employee Count	95,000
Asset Turnover	0.38
Inventory Turnover	2.06

Taxes

In the past 12 months, Medtronic has paid 4.88 billion in taxes.

Income Tax	4.88B
Effective Tax Rate	15.90%

Stock Price Statistics

The stock price has increased by +10.07% in the last 52 weeks. The beta is 0.74, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+10.07%
50-Day Moving Average	248.06
200-Day Moving Average	236.00
Relative Strength Index (RSI)	66.62
Average Volume (20 Days)	13

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.88

Income Statement

In the last 12 months, Medtronic had revenue of BRL 187.22 billion and earned 25.66 billion in profits. Earnings per share was 19.88.

Revenue	187.22B
Gross Profit	122.77B
Operating Income	36.62B
Pretax Income	30.69B
Net Income	25.66B
EBITDA	51.56B
EBIT	36.62B
Earnings Per Share (EPS)	19.88

Balance Sheet

The company has 44.85 billion in cash and 156.75 billion in debt, giving a net cash position of -111.68 billion.

Cash & Cash Equivalents	44.85B
Total Debt	156.75B
Net Cash	-111.68B
Net Cash Per Share	n/a
Equity (Book Value)	263.16B
Book Value Per Share	204.42
Working Capital	75.74B

Cash Flow

In the last 12 months, operating cash flow was 38.31 billion and capital expenditures -10.27 billion, giving a free cash flow of 28.04 billion.

Operating Cash Flow	38.31B
Capital Expenditures	-10.27B
Free Cash Flow	28.04B
FCF Per Share	n/a

Margins

Gross margin is 65.58%, with operating and profit margins of 19.56% and 13.71%.

Gross Margin	65.58%
Operating Margin	19.56%
Pretax Margin	16.39%
Profit Margin	13.71%
EBITDA Margin	27.54%
EBIT Margin	19.56%
FCF Margin	14.98%

Dividends & Yields

This stock pays an annual dividend of 5.85, which amounts to a dividend yield of 2.13%.

Dividend Per Share	5.85
Dividend Yield	2.13%
Dividend Growth (YoY)	9.62%
Years of Dividend Growth	1
Payout Ratio	75.86%
Buyback Yield	1.73%
Shareholder Yield	3.86%
Earnings Yield	3.70%
FCF Yield	4.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.91 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.91
Piotroski F-Score	7